A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Figure skater Michelle Hong used to hide her skin as much as possible due to her condition—but with effective treatment and ...

Doctors report a steady increase in eczema cases among infants across Indian cities. Experts warn that genetics and ...

Nektar Therapeutics stock launched Tuesday after the biotech company hit every goal in a midstage study of its eczema ...

Learn how Dupixent helps diverse eczema patients and why inclusive clinical trials are vital for fair healthcare.

In this video, Robert J. Smith, MD, discusses the many treatment options available to patients with atopic dermatitis.

Despite Nektar’s share price shooting up as much as 175% on Tuesday, William Blair maintained that “there is an absence of ...

Nektar Therapeutics shares doubled in early trading Tuesday after the U.S. biotech firm said it reached its targets in a midstage study of its eczema treatment.

Nektar, which accused Lilly of making errors in its analysis of the data, forged ahead with the programme and started the ...

Nektar Therapeutics (NKTR) saw its stock surge 86% Tuesday morning after reporting strong midstage trial results for its ...